Statistics for Phathom Pharmaceuticals (id:8015 PHAT)

Valuation metrics

Market cap

607.88M

Enterprise value

784.67M

Trailing P/E (ttm)

-2.38

Forward P/E

-2.22

PEG ratio

-2.22

Price/Sales (ttm)

23.14

Price/Book (mrq)

-3.23

Enterprise Value/Revenue

29.87

Enterprise Value/EBITDA

-2.73

Overview

Shares outstanding

68.38M

Float

55.75M

Shares short

17.45M

% Held by insiders

0.08%

% Held by institutions

1.10%

Average volume (10 days)

2.73M

Average volume (90 days)

Price summary

52-Week low

6.06

52-Week high

19.71

52-Week change

22.70%

Beta

0.72

50-Day moving average

16.58

200-Day moving average

12.14

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

75.51%

Operating margin

-432.95%

Operational effectiveness

Return on assets

-57.67%

Return on equity

277.07%

Income statement

Revenue (ttm)

0.44

Revenue per share (ttm)

0.44

Quarterly revenue growth (yoy)

Gross profit (ttm)

515.00K

EBITDA

-287,137,984.00

Net income to common (ttm)

-339,444,992.00

Diluted EPS (ttm)

-5.74

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

334.68M

Total cash per share (mrq)

4.90

Total debt (mrq)

518.99M

Total Debt/Equity (mrq)

-2.77

Current ratio (mrq)

572.60%

Book value per share (mrq)

-2.74

Cash flow

Cash flow statement

-247,111,008.00

Levered free cash flow (LFCF)

-179,773,248.00